The patient must receive insulin therapy to prevent ketoacidosis

The patient may have sufficient endogenous insulin to prevent ketoacidosis but is at risk for hyperosmolar hyperglycemic syndrome

The patient has minimal or absent endogenous insulin secretion and requires daily insulin injections

The patient has islet cell antibodies that have destroyed the pancreas’s ability to produce insulin